• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童癌症伴非中性粒细胞减少性发热:管理和结局的范围综述。

Nonneutropenic fever in children with cancer: A scoping review of management and outcome.

机构信息

The Paediatric Integrated Cancer Service, Parkville, Victoria, Australia.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

出版信息

Pediatr Blood Cancer. 2019 Jun;66(6):e27634. doi: 10.1002/pbc.27634. Epub 2019 Feb 5.

DOI:10.1002/pbc.27634
PMID:30724005
Abstract

To date, very few studies have addressed nonneutropenic fever (NNF) in children with cancer, and there are no consensus guidelines. This scoping review aims to describe the rate of bacteremia, risk factors for infection and management, and outcomes of NNF in this population. Across 15 studies (n = 4106 episodes), the pooled-average bacteremia rate was 8.2%, and risk factors included tunneled external central venous catheter, clinical instability, and higher temperature. In two studies, antibiotics were successfully withheld in a subset of low-risk patients. Overall outcomes of NNF appear favorable; however, further research is required to determine its true clinical and economic impact.

摘要

迄今为止,很少有研究涉及癌症患儿的非中性粒细胞减少性发热(NNF),也没有共识指南。本范围综述旨在描述该人群中 NNF 的菌血症发生率、感染的危险因素和治疗以及结局。在 15 项研究(n=4106 例)中,菌血症的汇总平均发生率为 8.2%,危险因素包括带隧道的中心静脉置管、临床不稳定和更高的体温。在两项研究中,一组低危患者成功地避免了使用抗生素。NNF 的总体结局似乎较好;然而,需要进一步的研究来确定其对临床和经济的真正影响。

相似文献

1
Nonneutropenic fever in children with cancer: A scoping review of management and outcome.儿童癌症伴非中性粒细胞减少性发热:管理和结局的范围综述。
Pediatr Blood Cancer. 2019 Jun;66(6):e27634. doi: 10.1002/pbc.27634. Epub 2019 Feb 5.
2
Bacteremia in febrile nonneutropenic pediatric oncology patients.发热性非中性粒细胞减少的儿科肿瘤患者的菌血症
Pediatr Blood Cancer. 2010 Jan;54(1):83-7. doi: 10.1002/pbc.22264.
3
Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.评估未给予经验性抗生素的发热、非中性粒细胞减少性儿科肿瘤患者的中心静脉导管。
J Pediatr. 2015 Jan;166(1):157-62. doi: 10.1016/j.jpeds.2014.09.008. Epub 2014 Oct 14.
4
Non-neutropenic fever in children with cancer: Management, outcomes and clinical decision rule validation.儿童癌症伴非中性粒细胞减少性发热的处理、结局和临床决策规则的验证。
Pediatr Blood Cancer. 2022 Dec;69(12):e29931. doi: 10.1002/pbc.29931. Epub 2022 Aug 28.
5
Reducing empiric antibiotic administration in pediatric oncology patients with non-neutropenic fever: a single-center quality improvement initiative.减少非中性粒细胞减少性发热的儿科肿瘤患者的经验性抗生素使用:一项单中心质量改进举措。
Pediatr Hematol Oncol. 2025 May;42(4):242-249. doi: 10.1080/08880018.2025.2498664. Epub 2025 May 7.
6
A clinical approach to non-neutropenic fever in children with cancer.癌症患儿非中性粒细胞减少性发热的临床处理方法
J Oncol Pharm Pract. 2021 Apr;27(3):560-569. doi: 10.1177/1078155220925161. Epub 2020 May 31.
7
Management of indwelling central venous catheters in pediatric cancer patients with fever and neutropenia.小儿癌症发热伴中性粒细胞减少患者留置中心静脉导管的管理
Scand J Infect Dis. 1993;25(3):357-64. doi: 10.3109/00365549309008511.
8
Outcomes and Disposition of Oncology Patients With Non-neutropenic Fever and Positive Blood Cultures.肿瘤患者中性粒细胞减少症发热和血培养阳性患者的结局和处置。
J Pediatr Hematol Oncol. 2021 Mar 1;43(2):47-51. doi: 10.1097/MPH.0000000000001878.
9
Ochrobactrum anthropi bacteremia in pediatric oncology patients.儿童肿瘤患者中的嗜水气单胞菌血症
Pediatr Infect Dis J. 2002 Jan;21(1):72-4. doi: 10.1097/00006454-200201000-00018.
10
A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.一项针对发热且中性粒细胞减少的儿科癌症患者微生物学确诊感染的前瞻性多中心研究:瑞士儿科肿瘤学组2003年发热与中性粒细胞减少研究
Pediatr Infect Dis J. 2014 Sep;33(9):e219-25. doi: 10.1097/INF.0000000000000326.

引用本文的文献

1
Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.前瞻性验证 Esbenshade Vanderbilt 模型可准确预测伴发热的无中性粒细胞减少症癌症患儿血流感染风险。
J Clin Oncol. 2024 Mar 1;42(7):832-841. doi: 10.1200/JCO.23.01814. Epub 2023 Dec 7.
2
Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.发热而无严重中性粒细胞减少的急性淋巴细胞白血病/淋巴瘤儿科患者的感染性事件评估。
Cancer. 2022 Dec 1;128(23):4129-4138. doi: 10.1002/cncr.34476. Epub 2022 Oct 13.
3
Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.
免疫抑制患者医疗护理中的感染预防要求:罗伯特·科赫研究所医院卫生与感染预防委员会(KRINKO)的建议
GMS Hyg Infect Control. 2022 Apr 13;17:Doc07. doi: 10.3205/dgkh000410. eCollection 2022.
4
Diagnostic Stewardship in the Pediatric Intensive Care Unit.儿科重症监护病房的诊断管理。
Infect Dis Clin North Am. 2022 Mar;36(1):203-218. doi: 10.1016/j.idc.2021.11.003.
5
Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children.优化儿童发热性中性粒细胞减少症治疗中的抗菌药物选择与疗程
Infect Drug Resist. 2021 Mar 30;14:1283-1293. doi: 10.2147/IDR.S238567. eCollection 2021.
6
[Not Available].[无可用内容]。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Feb;64(2):232-264. doi: 10.1007/s00103-020-03265-x.
7
Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.儿科肿瘤科中性粒细胞减少症发热患者严重不良事件的预测因素。
Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3487-3492. doi: 10.31557/APJCP.2020.21.12.3487.
8
Prospective Implementation of a Risk Prediction Model for Bloodstream Infection Safely Reduces Antibiotic Usage in Febrile Pediatric Cancer Patients Without Severe Neutropenia.前瞻性实施血流感染风险预测模型可安全减少无严重中性粒细胞减少的发热性儿科癌症患者的抗生素使用量。
J Clin Oncol. 2020 Sep 20;38(27):3150-3160. doi: 10.1200/JCO.20.00591. Epub 2020 Aug 7.
9
Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.癌症合并发热性中性粒细胞减少症患儿的风险分层:九种临床决策规则的全国性、前瞻性、多中心验证
EClinicalMedicine. 2020 Jan 7;18:100220. doi: 10.1016/j.eclinm.2019.11.013. eCollection 2020 Jan.